GlassScriptPhysician profile
Amy W Zhou
NPI 1831331990
$18,094.85
in general payments reported to CMS, 2019-2025
15 companies · $2,636 in 2025
The $2,636 reported for 2025 was more than what a typical Hematology (Internal Medicine) provider received nationally (typical 2025 total: $1,177).
See the full distribution for Hematology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,510 · 2022: $4,742 · 2023: $345 · 2024: $2,863 · 2025: $2,636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,800 · Food and Beverage: $1,011 · Education: $31.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,800.00 |
| Food and Beverage | $1,011.47 |
| Education | $31.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $7,704.01 | 2019-2025 | Jakafi, Jakafi, Niktimvo |
| Alexion Pharmaceuticals, INC. | $3,180.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $2,729.96 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $2,199.99 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $1,462.50 | 2022 | |
| Cti Biopharma Corp. | $313.22 | 2023 | Vonjo |
| Genzyme Corporation | $179.65 | 2024-2025 | |
| Sobi, INC | $107.20 | 2025 | |
| Chiesi USA, INC. | $97.83 | 2025 | Kengreal |
| Servier Pharmaceuticals LLC | $41.46 | 2025 | |
| Blueprint Medicines Corporation | $31.33 | 2023 | |
| Pharmaessentia USA Corporation | $17.51 | 2025 | Besremi |
| Recordati_rare_diseases_inc. | $15.15 | 2025 | Enjaymo |
| Hema Biologics, LLC | $15.04 | 2025 | Sevenfact |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.